This study examined lung resistance protein (LRP) and multidrug resistance protein (MRP) in lung tumour tissue from 92 patients with non-small cell lung cancer (NSCLC) and normal lung tissue from 20 patients with benign lung tumours. The rates for LRP- and MRP-positive tumours among the NSCLC cases were 54% and 59%, respectively, and their combined positive rate was 45%. These rates were significantly higher than in normal lung tissue. The rates of LRP- and MRP-positive tumours were significantly higher among cases of adenocarcinoma than in cases of squamous cell carcinoma, and in highly differentiated tumours compared with tumours of low or moderate differentiation. There was a significant association between LRP- and MRP-positive tumours and a decrease in overall survival. In conclusion, LRP and MRP play a role in multidrug resistance in NSCLC and are related to prognosis in patients with NSCLC.
MolinaJRYangPCassiviSD: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc2008; 83: 584–594.
2.
OkamotoTIchinoseY: Adjuvant chemotherapy for non-small cell lung cancer. Gan To Kagaku Ryoho2006; 33: 1985–1990 [in Japanese, English abstract].
3.
MonzoMRosellRTaronM: Drug resistance in non-small cell lung cancer. Lung Cancer2001; 34 (suppl 2): S91–S94.
4.
YoungLCCamplingBGColeSP: Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res2001; 7: 1798–1804.
5.
YoungLCCamplingBGNomikosT Voskoglou: Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin Cancer Res1999; 5: 673–680.
6.
LaurençotCMSchefferGLScheperRJ: Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int J Cancer1997; 72: 1021–1026.
7.
BergerWElblingLMickscheM: Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Int J Cancer2000; 88: 293–300.
8.
DingemansAMvan Ark-OtteJvan der ValkP: Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues. Ann Oncology1996; 7: 625–630.
9.
KlunderJWKomdeurRVan Der GraafWT: Expression of multidrug resistance-associated proteins in rhabdomyosarcomas before and after chemotherapy: the relationship between lung resistance-related protein (LRP) and differentiation. Hum Pathol2003; 34: 150–155.
10.
CanitrotYBichatFColeSP: Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy. Cancer Lett1998; 130: 133–141.
11.
LangeCWaltherWSchwabeH: Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. Biochem Biophys Res Commun2000; 278: 125–133.
12.
VolmMKoomägiRMatternJ: Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer2002; 87: 251–257.
13.
MeschiniSMarraMCalcabriniA: Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. Toxicol In Vitro2002; 16: 389–398.
14.
SunZYYuHYLiuHM: Expression of multiple drug resistance-associated proteins in non-small cell lung cancer tissues and its clinical significance. Tumor2007; 27: 303–307 [in Chinese].
15.
GoldsteinLJGalskiHFojoA: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst1989; 81: 116–124.
16.
YuWXiangFWangR: The quantitative analysis of lung resistant protein in NSCLC and its clinical significance. Acta Academiae Medicinae Qingdao Universitatis2007; 43: 64–66 [in Chinese].
17.
XuJZhouCYiX: The expression of lung resistant protein and multi-drug resistance protein in NSCLC. Doctor Advanced Periodica (Medicine)2004; 27: 41–42 [in Chinese].
18.
LiX-QLiJChenP: Expression and clinical significance of MRP1 and LRP mRNA in non-small cell lung cancer. Practical J Cancer2008; 23: 145–147 [in Chinese].
19.
YuSPXiongYYTianSF: Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma. Zhonghua Jie He He Hu Xi Za Zhi2003; 26: 165–168 [in Chinese, English abstract].
20.
CheC-IHuoJ-M: Clinical mean of expression of multi-drug resistance protein in non-small cell lung cancer. J Harbin Medical University2006; 40: 309–311 [in Chinese].
21.
LiJLiZNYuLC: Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy. Lung Cancer2010; 69: 116–122.
